NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
* Return to Hematology Alert Section

New chronic myeloid leukemia study findings recently were reported by researchers at Tangdu Hospital, Department of Hematology



December 29th, 2008

   2008 DEC 29 -- New research, 'Notch signaling inhibits the growth of the human chronic myeloid leukemia cell line K562,' is the subject of a report. According to a study from People's Republic of China, "Notch signaling functions in the development of some types of leukemia and lymphoma, but the relationship between Notch signaling and chronic myeloid leukemia (CML) remains to be elucidated. In this study, we examined the expression of Notch receptors and ligands in the human CML cell line K562."

   "When the active form of Notch1, the Notch intra-cellular domain (NIC), was over-expressed in K562, the proliferation of K562 was mildly but significantly inhibited, accompanied by increased Hes1 mRNA level. On the other hand, when Notch signaling was attenuated by over-expression of a dominant-negative RBP-J, RBP-J(R218H), in K562 cells, the proliferation of K562 was increased. Moreover, we found that activation of Notch signaling inhibited while repression of Notch signaling promoted the colony-forming activity of K562 cells. We examined cell cycle-related molecules in K562 transfected with NIC or RBP-J(R218H), and found that the protein level of the retinoblastoma gene product (the Rb protein) was induced in K562 expressing NIC, and down-regulated in K562 expressing RBP-J(R218H)," wrote D.D. Yin and colleagues, Tangdu Hospital, Department of Hematology.

   The researchers concluded: "These data suggest that the Notch signaling may function as a tumor inhibitor in human CML cells."

   Yin and colleagues published their study in Leukemia Research (Notch signaling inhibits the growth of the human chronic myeloid leukemia cell line K562. Leukemia Research, 2009;33(1):109-14).

   For more information, contact D.D. Yin, Tangdu Hospital, Dept. of Hematology, Xi'an 710038, China.

   Publisher contact information for the journal Leukemia Research is: Pergamon-Elsevier Science Ltd., the Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, England.

   Keywords: People's Republic of China, Chronic Myeloid Leukemia, Hematology, Lymphoma, Oncology.

   This article was prepared by Hematology Week editors from staff and other reports. Copyright 2008, Hematology Week via NewsRx.com.

Return to Hematology Alert Section

NewsRx Passes
Advertisement
------------------------
Security by Verisign PR Login